Jump to content

RNF213

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by OAbot (talk | contribs) at 05:02, 13 April 2020 (Open access bot: hdl, doi added to citation with #oabot.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

RNF213
Identifiers
AliasesRNF213, ALO17, C17orf27, KIAA1618, MYMY2, MYSTR, NET57, ring finger protein 213
External IDsOMIM: 613768; MGI: 1289196; HomoloGene: 45439; GeneCards: RNF213; OMA:RNF213 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

57674

672511

Ensembl

ENSG00000173821

ENSMUSG00000070327

UniProt

Q63HN8

n/a

RefSeq (mRNA)

NM_001256071
NM_020914
NM_020954

NM_001040005

RefSeq (protein)

NP_001243000
NP_066005

n/a

Location (UCSC)Chr 17: 80.26 – 80.4 MbChr 11: 119.28 – 119.38 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Ring finger protein 213 is a protein that in humans is encoded by the RNF213 gene.[5] RNF213 is a 591kDa cytosolic E3 Ubiquitin-ligase with RING finger and AAA+ ATPase domains.

Clinical relevance

Chromosome-wide linkage analysis found that moyamoya disease locus resides in chromosome 17q25.[6] Genome-wide linkage analysis of 15 Japanese families of autosomal dominant moyamoya disease narrowed down the locus to 17q25.3.[7] Direct sequencing of the region and whole-exome sequencing identified the p.Arg4810Lys mutation in RNF213 gene as a founder mutation of moyamoya disease.[8] A genome-wide association study also identified RNF213 as a disease causing gene for Moyamoya disease.[9] Comparative evolutionary genome sequencing analyses in humans and monkeys showed that the strongest evidence for acceleration along the branch leading to hominines was RNF213.[10] RNF213 has been shown to be associated with blood flow and oxygen consumption.[11][12][13] Given that oxygen and glucose consumption scales with total neuron number, RNF213 may have played a role in facilitating the evolution of larger brains in primates.[10]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000173821 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000070327 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ "Entrez Gene: ring finger protein 213".
  6. ^ Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, et al. (April 2000). "Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25". Stroke. 31 (4): 930–5. doi:10.1161/01.str.31.4.930. PMID 10754001.
  7. ^ Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, et al. (June 2008). "Autosomal dominant moyamoya disease maps to chromosome 17q25.3". Neurology. 70 (24 Pt 2): 2357–63. doi:10.1212/01.wnl.0000291012.49986.f9. hdl:2433/135797. PMID 18463369.
  8. ^ Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. (Jul 2011). "Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development". PLOS ONE. 6 (7): e22542. doi:10.1371/journal.pone.0022542. PMC 3140517. PMID 21799892.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  9. ^ Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. (January 2011). "A genome-wide association study identifies RNF213 as the first Moyamoya disease gene". Journal of Human Genetics. 56 (1): 34–40. doi:10.1038/jhg.2010.132. PMID 21048783.
  10. ^ a b Scally A, Dutheil JY, Hillier LW, Jordan GE, Goodhead I, Herrero J, et al. (March 2012). "Insights into hominid evolution from the gorilla genome sequence". Nature. 483 (7388): 169–75. doi:10.1038/nature10842. PMC 3303130. PMID 22398555.
  11. ^ Banh RS, Iorio C, Marcotte R, Xu Y, Cojocari D, Rahman AA, et al. (July 2016). "PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia". Nature Cell Biology. 18 (7): 803–813. doi:10.1038/ncb3376. PMC 4936519. PMID 27323329.
  12. ^ Kobayashi H, Kabata R, Kinoshita H, Morimoto T, Ono K, Takeda M, et al. (May 2018). "Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in mice". Pulmonary Circulation. 8 (3): 2045894018778155. doi:10.1177/2045894018778155. PMC 5991195. PMID 29718794.
  13. ^ Morimoto T, Enmi JI, Hattori Y, Iguchi S, Saito S, Harada KH, et al. (February 2018). "Dysregulation of RNF213 promotes cerebral hypoperfusion". Scientific Reports. 8 (1): 3607. doi:10.1038/s41598-018-22064-8. PMC 5827518. PMID 29483617.

Further reading


Stub icon

This article on a gene on human chromosome 17 is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=RNF213&oldid=950650983"